Read time: 25 min Lipid nanoparticles (LNPs) are widely used vehicles for oligonucleotide-based therapeutics and vaccines. However, LNPs can be susceptible to N-oxide-based impurities that can cause messenger RNA (mRNA) to lose function. In a recent live webinar, now...
Author Highlights
Matthew Stone
Matthew Stone currently works at SCIEX as a biologics workflow specialist focusing on business development for life sciences research and biopharma applications, in particular next generation biologics. He received a BA in chemistry at Carleton College in Northfield, Minnesota and later earned a PhD in biochemistry at the University of Minnesota which focused on the development of protein derivatives of factor VIIa with enhanced activity as potential enzyme replacement therapies. He did post-doctoral research at the National Institute on Aging using mass spectrometry-based functional proteomics and also worked at the University of Minnesota Center for Mass Spectrometry and Proteomics core facility on various collaborative proteomics-based research projects.